Junge Zhang
Direttore/Membro del Consiglio presso OCUGEN, INC.
Patrimonio netto: 2 M $ in data 31/05/2024
Profilo
Junge Zhang is the founder of Biopeptek Pharmaceuticals LLC, where he holds the title of President & Chief Executive Officer starting in 2010.
He is also the founder of Mainline Scientific LLC and Mainline Biosciences, Inc. Currently, he holds the position of Independent Director at Ocugen, Inc. since 2019 and Director at Ocugen OpCo, Inc. since 2015.
He previously held the position of Director at Ocugen, Inc. Dr. Zhang holds a doctorate degree from Drexel University, an undergraduate degree from Wuhan University of Technology, and a graduate degree from the University of Louisiana System.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
OCUGEN INC
0.45% | 10/05/2024 | 1 165 182 ( 0.45% ) | 2 M $ | 31/05/2024 |
Posizioni attive di Junge Zhang
Società | Posizione | Inizio |
---|---|---|
OCUGEN, INC. | Direttore/Membro del Consiglio | 01/09/2019 |
Ocugen OpCo, Inc. | Direttore/Membro del Consiglio | 01/05/2015 |
Biopeptek Pharmaceuticals LLC | Amministratore Delegato | 01/10/2010 |
Mainline Biosciences, Inc.
Mainline Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Mainline Biosciences, Inc. manufactures pharmaceutical products. The private company is based in Malvern. The American company was founded by Junge Zhang. Junge Zhang has been the CEO since incorporation. | Amministratore Delegato | - |
Precedenti posizioni note di Junge Zhang
Società | Posizione | Fine |
---|---|---|
Mainline Scientific LLC | Fondatore | - |
Ocugen, Inc. /Old/
Ocugen, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Ocugen, Inc. operates as a clinical stage biopharmaceutical firm. It discovers, develops, and commercializes therapies for rare and underserved eye diseases. The firm offers a robust and diversified ophthalmology portfolio that includes novel gene therapies, biologics, and small molecules. The company was founded by Shankar Musunuri and Uday Kompella in 2013 and is headquartered in Malvern, PA. | Direttore/Membro del Consiglio | - |
Formazione di Junge Zhang
Drexel University | Doctorate Degree |
University of Louisiana System | Graduate Degree |
Wuhan University of Technology | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
OCUGEN, INC. | Health Technology |
Aziende private | 5 |
---|---|
Ocugen, Inc. /Old/
Ocugen, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Ocugen, Inc. operates as a clinical stage biopharmaceutical firm. It discovers, develops, and commercializes therapies for rare and underserved eye diseases. The firm offers a robust and diversified ophthalmology portfolio that includes novel gene therapies, biologics, and small molecules. The company was founded by Shankar Musunuri and Uday Kompella in 2013 and is headquartered in Malvern, PA. | Health Technology |
Ocugen OpCo, Inc. | |
Biopeptek Pharmaceuticals LLC | |
Mainline Biosciences, Inc.
Mainline Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Mainline Biosciences, Inc. manufactures pharmaceutical products. The private company is based in Malvern. The American company was founded by Junge Zhang. Junge Zhang has been the CEO since incorporation. | Health Technology |
Mainline Scientific LLC |
- Borsa valori
- Insiders
- Junge Zhang